Instead, our results support the emerging view that α-synuclein may exert its cytotoxic effects primarily on endocytic and vesicle trafficking pathways [87], with the reported mitochondrial damage in postmortem PD brains being a secondary, subsequent consequence of the disease process [57,82]. The gene discussed is SNCA; the disease is Parkinson disease.